DJIA 16,501.65 -12.72 -0.08%
NASDAQ 4,126.97 0.00 0.00%
S&P 500 1,875.39 -4.16 -0.22%
market minute promo

36.96 0.14 (0.38%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ENTA $36.96 0.38%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $37.11
Previous Close $36.82
Daily Range $35.60 - $37.25
52-Week Range $16.18 - $43.73
Market Cap $678.7M
P/E Ratio -15.21
Dividend (Yield) $0.00 (0.0%)
Volume 151,279
Average Daily Volume 332,043
Current FY EPS $1.47

Sector

Industry

Enanta Pharmaceuticals, Inc. (ENTA) Description

Enanta Pharmaceuticals, Inc. Website: http://www.enanta.com/

News & Commentary Rss Feed

Biotech Losers: InterMune, Enanta, and GW Pharmaceuticals

Here's what dragged down InterMune, Enanta, and GW Pharmaceuticals in the biotech space this week.

Dr. Reddy's Launches Generic Antara - Analyst Blog

AbbVie Files for HCV Combination Therapy in U.S. - Analyst Blog

Karyopharm Starts Phase I Study - Analyst Blog

Karyopharm Starts Phase I Study - Analyst Blog

Galectin Therapeutics Rises on GR-MD-02 Update - Analyst Blog

Has A Streamlined FDA Raised The Value Of Drug Stocks?

Dr. Reddy's Launches Generic Lunesta - Analyst Blog

Legal Settlement for Astellas Pharma - Analyst Blog

Legal Settlement for Astellas Pharma - Analyst Blog

Positive Data on AbbVie's HCV Program - Analyst Blog

Positive Data on AbbVie's HCV Program - Analyst Blog

Commit To Purchase Enanta Pharmaceuticals At $35, Earn 20.7% Annualized Using Options

AbbVie HCV Combination Therapy Data Looks Good - Analyst Blog

See More ENTA News...